Chair: Lowell Kabnick & Michael Dake
12:45 |
Welcome & Introduction
|
13:10 |
Etiology of deep vein thrombosis (VDT) - Michael Dake |
13:20 |
Etiology and pathophysiology of PTS - Oliver Schlager |
13:20 |
The myth of May Thurner - Irwin Toonder |
13:30 |
Immediate vs. late stenting of May Thurner Syndrome after DVT thrombolysis - Mahmoud Razavi |
13:55 |
Operators: Michael Lichtenberg & Rick de Graaf |
Chair: Mahmoud Razavi & Irwin Toonder
14:45 |
|
14:55 | |
15:05 |
IVUS in deep venous treatment: key findings from the VIDIO trial - Lukasz Dzieciuchowicz |
15:15 |
Predisposing factors to stent fractures: are stent fractures important? - Mahmoud Razavi |
15:25 |
VenovoTM venous stent 12 months update on the Vernacular trial - Michael Dake |
15:55 |
Operators: Michael Lichtenberg & Rick de Graaf |
Chair: Nils Kucher & Olivier Hartung
Chair: Michael Lichtenberg & Oliver Schlager
Chair: Olivier Hartung & Mert Dumantepe
11:00 | |
11:10 | |
11:20 |
|
11:30 |
Anticoagulation regime after DVT and venous stenting - Oliver Schlager |
11:40 |
The classification of CVO and its clinical impact - Houman Jalaie |
Chair: Lowell Kabnick & Houman Jalaie
Chair: Thomas Heller & Rick de Graaf
14:30 | |
14:55 |
There is no evidence that stent characteristics affect the outcome - Olivier Hartung & Oliver Schlager |
15:20 |
0Join the discussion
VENOUS SUMMIT 2019 - Discussion